Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin B Steins

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Pneumologie (Stuttgart, Germany)|May 16, 2017
[Pain Management in Palliative Care]Martin B Steins, Corinna Eschbach, Matthias Villalobos, et al.
Onkologie|December 3, 2010
Targeting the epidermal growth factor receptor in non-small cell lung cancerMartin B Steins, Niels Reinmuth, Helge Bischoff, et al.
Oncology Reports|April 17, 2002
Carboplatin/etoposide induces remission of metastasised malignant peripheral nerve tumours (malignant schwannoma) refractory to first-line therapyMartin B Steins, Hubert Serve, Michael Zühlsdorf, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|June 19, 2004
Overexpression of urokinase receptor and cell surface urokinase-type plasminogen activator in the human vessel wall with different types of atherosclerotic lesionsMartin B Steins, Teresa Padró, Carsten Schwaenen, et al.
Transfusion|August 5, 2005
The influence of blood group differences in allogeneic hematopoietic peripheral blood progenitor cell transplantationChristian G Erker, Martin B Steins, Rudolf-Josef Fischer, et al.
Blood|January 25, 2002
Efficacy and safety of thalidomide in patients with acute myeloid leukemiaMartin B Steins, Teresa Padró, Ralf Bieker, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 26, 2011
Randomized phase II study of erlotinib in combination with placebo or R1507, a monoclonal antibody to insulin-like growth factor-1 receptor, for advanced-stage non-small-cell lung cancerSuresh S Ramalingam, David R Spigel, David Chen, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Pneumologie (Stuttgart, Germany)|May 16, 2017
[Pain Management in Palliative Care]Martin B Steins, Corinna Eschbach, Matthias Villalobos, et al.
Onkologie|December 3, 2010
Targeting the epidermal growth factor receptor in non-small cell lung cancerMartin B Steins, Niels Reinmuth, Helge Bischoff, et al.
Oncology Reports|April 17, 2002
Carboplatin/etoposide induces remission of metastasised malignant peripheral nerve tumours (malignant schwannoma) refractory to first-line therapyMartin B Steins, Hubert Serve, Michael Zühlsdorf, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|June 19, 2004
Overexpression of urokinase receptor and cell surface urokinase-type plasminogen activator in the human vessel wall with different types of atherosclerotic lesionsMartin B Steins, Teresa Padró, Carsten Schwaenen, et al.
Transfusion|August 5, 2005
The influence of blood group differences in allogeneic hematopoietic peripheral blood progenitor cell transplantationChristian G Erker, Martin B Steins, Rudolf-Josef Fischer, et al.
Blood|January 25, 2002
Efficacy and safety of thalidomide in patients with acute myeloid leukemiaMartin B Steins, Teresa Padró, Ralf Bieker, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 26, 2011
Randomized phase II study of erlotinib in combination with placebo or R1507, a monoclonal antibody to insulin-like growth factor-1 receptor, for advanced-stage non-small-cell lung cancerSuresh S Ramalingam, David R Spigel, David Chen, et al.
Pageof 1